Financial Advocates Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$248K Sell
2,239
-1,959
-47% -$217K 0.02% 539
2025
Q1
$470K Sell
4,198
-4,541
-52% -$509K 0.03% 437
2024
Q4
$807K Sell
8,739
-6,372
-42% -$589K 0.05% 351
2024
Q3
$1.27M Buy
15,111
+665
+5% +$55.8K 0.07% 257
2024
Q2
$991K Buy
14,446
+5,526
+62% +$379K 0.06% 293
2024
Q1
$653K Buy
8,920
+729
+9% +$53.4K 0.04% 401
2023
Q4
$664K Buy
8,191
+308
+4% +$25K 0.04% 369
2023
Q3
$591K Buy
7,883
+282
+4% +$21.1K 0.04% 374
2023
Q2
$586K Sell
7,601
-951
-11% -$73.3K 0.04% 365
2023
Q1
$710K Sell
8,552
-2,243
-21% -$186K 0.05% 348
2022
Q4
$927K Buy
10,795
+6,186
+134% +$531K 0.07% 302
2022
Q3
$275K Sell
4,609
-5,295
-53% -$316K 0.02% 569
2022
Q2
$612K Buy
9,904
+2,719
+38% +$168K 0.05% 359
2022
Q1
$427K Buy
7,185
+2,845
+66% +$169K 0.03% 480
2021
Q4
$321K Sell
4,340
-2,877
-40% -$213K 0.02% 610
2021
Q3
$504K Buy
7,217
+2,198
+44% +$153K 0.03% 470
2021
Q2
$347K Sell
5,019
-1,805
-26% -$125K 0.02% 557
2021
Q1
$441K Buy
6,824
+88
+1% +$5.69K 0.03% 497
2020
Q4
$393K Buy
6,736
+1,485
+28% +$86.6K 0.03% 493
2020
Q3
$332K Buy
5,251
+430
+9% +$27.2K 0.03% 449
2020
Q2
$371K Sell
4,821
-1,411
-23% -$109K 0.04% 400
2020
Q1
$466K Buy
6,232
+2,621
+73% +$196K 0.07% 284
2019
Q4
$235K Sell
3,611
-869
-19% -$56.6K 0.03% 450
2019
Q3
$284K Sell
4,480
-471
-10% -$29.9K 0.03% 385
2019
Q2
$334K Sell
4,951
-1,561
-24% -$105K 0.04% 354
2019
Q1
$423K Sell
6,512
-1,635
-20% -$106K 0.05% 302
2018
Q4
$509K Sell
8,147
-1,255
-13% -$78.4K 0.07% 241
2018
Q3
$726K Buy
+9,402
New +$726K 0.08% 229
2018
Q1
Sell
-8,477
Closed -$607K 503
2017
Q4
$607K Buy
+8,477
New +$607K 0.08% 230